MelaNostrum Consortium Members
Criteria for Membership
MelaNostrum Consortium
For investigators not part of a group already working in the Consortium and potentially bringing with him/her other people from their group:
- The candidate must contribute data and/or biospecimens from melanoma patients (sporadic and/or familial, and possibly healthy controls) for the Consortium's projects. A brief description of the studies and related material that the candidate can contribute should be made available to all MelaNostrum PIs for their consideration.
- The candidate must respect absolute confidentiality about any discussion of data/projects within the Consortium. Failure to observe this requirement may result in exclusion from the Consortium.
- The candidate can be introduced by an existing member of MelaNostrum who can speak for his/her high quality of work and discretion. A candidate may alternatively approach the Consortium directly with the request to participate, in which case the decision to accept the request will be determined by the MelaNostrum PIs.
- The candidate or a person from his/her group should strive to participate in person in each annual meeting.
- The decision on whether to accept a new member or not should be made collegially by the MelaNostrum PIs. The decision can be communicated to Dr. Maria Teresa Landi privately by email and if consensus is not reached and more discussion is required, a decision may be postponed to the Consortium annual meeting.
If the candidate is a member of a group already working in MelaNostrum, it is enough if the PI who invites the person explains why he/she wants to bring this person and the type of expertise that this candidate can bring (e.g. in genetics, statistics, or molecular biology).
United States
Department of Health and Human Services
National Institutes of Health
National Cancer Institute, Division of Cancer Epidemiology and Genetics
Maria Teresa Landi (PI)
Kevin Brown
Spain
Barcelona Susana Puig (PI) |
València Eduardo Nagore (PI)
Madrid Pablo Ortiz-Romero (PI) |
Italy
Cesena L'Aquila Department of Dermatology University of L'Aquila Padua Cancer Genomics Program |
Genoa Medical Oncology Unit |
Rome San Gallicano Dermatological Institute – IRCCS, IFO |
Milan Department of Experimental Oncology and Molecular Medicine Fondazione IRCCS Istituto Nazionale dei Tumori Monica Rodolfo (PI) Florence Perugia |
Greece
Athens National and Kapodistrian University of Athens School of Medicine Andreas Sygros Hospital Alex Stratigos (PI) Evangelos Evangelou Helen Gogas Katerina Kypreou Irene Stefanaki |
Ioannina |
Cyprus
Cyprus
Nicosia Department of Electron Microscopy/Molecular Pathology
The Cyprus Institute of Neurology and Genetics
The Cyprus School of Molecular Medicine
France
Nice
Laboratory of Clinical and Experimental Pathology, Nice University Hospital
Nice Hospital-integrated Biobank, University of Côte d'Azur
Paul Hofman (PI)
Elodie Long-Mira
Croatia
Croatia
Department of Dermatology and Venereology, Sestre Milosrdnice University Hospital Centre
School of Dental Medicine, University of Zagreb
Mirna Šitum (PI)
Marija Buljan